Correlation Between Apogee Therapeutics, and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Nuvalent, you can compare the effects of market volatilities on Apogee Therapeutics, and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Nuvalent.
Diversification Opportunities for Apogee Therapeutics, and Nuvalent
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apogee and Nuvalent is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Nuvalent go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Nuvalent
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Nuvalent. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 1.26 times less risky than Nuvalent. The stock trades about -0.03 of its potential returns per unit of risk. The Nuvalent is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 8,467 in Nuvalent on August 28, 2024 and sell it today you would earn a total of 1,095 from holding Nuvalent or generate 12.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apogee Therapeutics, Common vs. Nuvalent
Performance |
| Timeline |
| Apogee Therapeutics, |
| Nuvalent |
Apogee Therapeutics, and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apogee Therapeutics, and Nuvalent
The main advantage of trading using opposite Apogee Therapeutics, and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Apogee Therapeutics, vs. VirnetX Holding Corp | Apogee Therapeutics, vs. Joint Stock | Apogee Therapeutics, vs. PennantPark Investment | Apogee Therapeutics, vs. ServiceNow |
| Nuvalent vs. Eliem Therapeutics | Nuvalent vs. Scpharmaceuticals | Nuvalent vs. Milestone Pharmaceuticals | Nuvalent vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |